Next Article in Journal
Inactivation of Anandamide Signaling: A Continuing Debate
Next Article in Special Issue
Echinacea—A Source of Potent Antivirals for Respiratory Virus Infections
Previous Article in Journal
Allosteric Modulation of G Protein Coupled Receptors by Cytoplasmic, Transmembrane and Extracellular Ligands
Open AccessReview

Anti-Viral Drugs for Human Adenoviruses

School of Biomedical Sciences, Croucher Laboratory for Human Genomics, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong
Author to whom correspondence should be addressed.
Pharmaceuticals 2010, 3(10), 3343-3354;
Received: 2 September 2010 / Revised: 23 October 2010 / Accepted: 25 October 2010 / Published: 25 October 2010
(This article belongs to the Special Issue Antivirals)
There are many stages in the development of a new drug for viral infection and such processes are even further complicated for adenovirus by the fact that there are at least 51 serotypes, forming six distinct groups (A–F), with different degree of infectivity. This review attempts to address the importance of developing pharmaceuticals for adenovirus and also review recent development in drug discovery for adenovirus, including newer strategies such as microRNA approaches. Different drug screening strategies will also be discussed. View Full-Text
Keywords: adenovirus; pharmaceuticals; microRNA adenovirus; pharmaceuticals; microRNA
Show Figures

Figure 1

MDPI and ACS Style

Waye, M.M.Y.; Sing, C.W. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals 2010, 3, 3343-3354.

AMA Style

Waye MMY, Sing CW. Anti-Viral Drugs for Human Adenoviruses. Pharmaceuticals. 2010; 3(10):3343-3354.

Chicago/Turabian Style

Waye, Mary Miu Yee; Sing, Chor Wing. 2010. "Anti-Viral Drugs for Human Adenoviruses" Pharmaceuticals 3, no. 10: 3343-3354.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop